• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Sunday, June 28, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News

EU Excellence Award for research on matter-antimatter plasma

Bioengineer by Bioengineer
April 6, 2017
in Science News
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
IMAGE

Credit: Graphic: IPP

The European Research Council (ERC) is awarding 2.4 million euros in support of the research on a matter-antimatter plasma composed of electrons and positrons to be produced for the first time in the world by Professor Dr. Thomas Sunn Pedersen at Max Planck Institute for Plasma Physics (IPP) in Greifswald. He is to receive one of the coveted Advanced Grants with which ERC supports pioneering, but risky research projects.

Just minutes after the big bang the universe was filled with equal amounts of matter and antimatter. A similar state is now to be produced by Professor Thomas Sunn Pedersen for the first time in the laboratory: a plasma composed of electrons and their antiparticles, viz. positrons. His objective is to confine an electron-positron plasma in a magnetic cage for at least ten minutes – long enough to allow exact investigation.

Extraordinary properties are predicted by plasma theory for electron-positron plasmas. They are expected to behave very differently to the "ordinary" plasmas produced by ionisation of atoms that are used in industry and fusion research. These plasmas are composed of light electrons and heavy ions, whereas electrons and positrons have exactly the same mass. This rids the exotic plasma of the mass difference between the positively and negatively charged plasma particles – the driving force behind the complex behaviour of ordinary plasmas, in which oscillations, waves, instabilities and turbulence develop. Investigating the computer codes used in fusion research on these exotic plasmas is therefore of great interests. But new discoveries are expected in astrophysics as well since it is assumed that electron-positron plasmas occur in the vicinity of neutron stars and black holes.

As in the universe, also the electron-positron plasma in the laboratory is to be confined by a magnetic dipole field. In the planned APEX-D device (A Positive Positron-Electron Experiment Dipole) the field is produced by a circular superconducting magnet coil. In a cylindrical ca. 20 litre vacuum vessel this coil is levitated by a ring-shaped conductor which is installed above the vessel and attracts the coil feedback-controlled. Similar devices have already been realised in the USA and Japan with ordinary plasmas. The electrons are to be injected into APEX-D with an electron gun. The positrons are to be supplied from the world's most powerful positron source by the FRM II research neutron source at the Technical University of Munich.

Once equal amounts of electrons and positrons are successfully fed into the magnetic trap the cold low-density plasma is expected to stay confined for hours, if not days, till all particles with their antiparticles have annihilated themselves pairwise in tiny flashes of energy – provided there is actually no turbulence in the electron-positron plasma as predicted by theory.

Encouraged by a series of successful preliminary experiments – e.g. positrons have already been trapped with an efficiency of 90 per cent in a device with an APEX-like field geometry – and spurred on by the funding awarded, the APEX-D project can now continue construction. Scientists from the Technical University of Munich, the University of Greifswald, where Thomas Sunn Pedersen teaches as professor, the University of California San Diego, USA, and the National Institute for Fusion Science in Toki, Japan, are major cooperation partners.

###

The European Research Council (ERC) was established in 2007 to support frontier research projects throughout Europe. Its grants, awarded annually, rank amongst the most attractive funding awarded in the context of the European Research Framework Programme. The only selection criterion is the researcher's scientific excellence and the innovative potential of the research idea. Furthermore, the planned project must be incorporated in a European scientific facility or in a country associated with the Framework Programme.

Media Contact

Isabella Milch
[email protected]

http://www.ipp.mpg.de/

############

Story Source: Materials provided by Scienmag

Share12Tweet8Share2ShareShareShare2

Related Posts

Tracking Lanthanide-Labeled Microplastics in Plants

June 25, 2026

POSTECH Researchers Slash Cost of Reconstituted Cell-Free Systems by 95%

June 25, 2026

AI and Physics Collaborate to Design Advanced Hydrogen Storage Materials

June 25, 2026

Natural Hallucinogens: Evolution’s Ecological Tools, Not Mere Chemical Byproducts

June 25, 2026
Please login to join discussion

POPULAR NEWS

  • Saying Goodbye to PGY-6: Pediatric Fellowship Realities

    103 shares
    Share 41 Tweet 26
  • Multi-Hospital Study Reveals Long Covid Burden Is Twice as High as Current Estimates

    92 shares
    Share 36 Tweet 23
  • Detection of EDCs in Breast Milk and Infant Urine Up to Six Months Highlights Early Exposure Risks

    77 shares
    Share 31 Tweet 19
  • New Drug Candidate Developed at McMaster Shows Potential for Treating Brain Cancer

    58 shares
    Share 23 Tweet 15

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Tracking Lanthanide-Labeled Microplastics in Plants

POSTECH Researchers Slash Cost of Reconstituted Cell-Free Systems by 95%

AI and Physics Collaborate to Design Advanced Hydrogen Storage Materials

Subscribe to Blog via Email

Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm' to start subscribing.

Join 82 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.